Biochemical Evaluation of Metformin and GLP-1 Therapy in Amelioration Metabolic Disturbance in Rats Induced Type II Diabetes

An AMPK activator, Metformin, ameliorates aging-related oxidative hepatic injury induced by D-galactose via Irisin/ SIRT1 pathway, a possible role of PPAR-γ besides its antioxida

Biochemical and histopathological evaluation of the effect of metformin and metformin nanoparticles against alloxan-induced diabetes in Rats

The Glucoregulatory Mechanisms, Pharmacokinetics and Pharmacogenetics of Metformin in Type 2 Diabetes Mellitus

Synthesis and Characterization of New Derivatives Of Metformin with Expected Anti-diabetic Effects

Modulation of MicroRNA 103 and 107 in Obese Newly Diagnosed Diabetic and T2DM Patients Maintained on Metformin

Metformin treatment improves the hepato-renal dysfunctions induced in Type-II diabetes in male rats

DEVELOPMENT OF A NOVEL METABOLIC GLYCO-SENSING APPROACH WITH ANTI-AGING POTENTIAL

Pathophysiological mechanisms of type 2 diabetes mellitus and the effects of metformin treatment in adult male albino rats.

The superiority of the nanoparticle form of metformin over its conventional form on glucose levels and SIRT -1 gene expression in diabetic male rats